Combined Radiation-Immunotherapy in locally advanced Bladder Cancer Prospective, single-arm, multicenter Phase-II Study to evaluate Safety and Efficacy of preoperative Radioimmunotherapy followed by radical Cystectomy in locally advanced Bladder Cancer (RACE-IT) - AB 65/18 of AUO

被引：0
|
作者：
Rexer, H. [1 ]
Schmid, S. [2 ]
Merseburger, A. [3 ]
机构：
[1] AUO Geschaftsstelle, Seestr 11, D-17252 Schwarz, Germany
[2] Tech Univ Munich, Klin Prufung LKP, Klinikum RDI, Urol Klin & Poliklin, Ismaninger Str 22, D-81675 Munich, Germany
[3] Deutsch Krebsgesell eV, Arbeitsgemeinschaft Urol Onkol, Kuno Fischer Str 8, D-14057 Berlin, Germany
来源：
AKTUELLE UROLOGIE | 2020年 / 51卷 / 02期
关键词：
D O I：
10.1055/a-1017-4964
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / 102
页数：2
相关论文
共 40 条
  • [11] Anlotinib combined with radiotherapy in locally advanced non-small cell lung cancer (LANSCLC): A prospective, single-arm, phase II study
    Ning, P.
    Chang, H.
    Zhang, J.
    Rong, P.
    Liu, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S944 - S944
  • [12] Efficacy and safety of camrelizumab combined with oxaliplatin and S-1 as neoadjuvant treatment in locally advanced gastric or gastroesophageal junction cancer: A phase II, single-arm study
    Zhong, Wen-Jin
    Lin, Jian-An
    Wu, Chu-Ying
    Wang, Jiantian
    Chen, Jun-Xing
    Zheng, Huida
    Ye, Kai
    CANCER MEDICINE, 2024, 13 (03):
  • [13] Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
    Shi, Jinming
    Li, Ning
    Tang, Yuan
    Jiang, Liming
    Yang, Lin
    Wang, Shulian
    Song, Yongwen
    Liu, Yueping
    Fang, Hui
    Lu, Ningning
    Qi, Shunan
    Chen, Bo
    Li, Ziyu
    Liu, Shixin
    Wang, Jun
    Wang, Wenling
    Zhu, Suyu
    Yang, Jialin
    Li, Yexiong
    Zhao, Dongbing
    Jin, Jing
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [14] Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
    Jinming Shi
    Ning Li
    Yuan Tang
    Liming Jiang
    Lin Yang
    Shulian Wang
    Yongwen Song
    Yueping Liu
    Hui Fang
    Ningning Lu
    Shunan Qi
    Bo Chen
    Ziyu Li
    Shixin Liu
    Jun Wang
    Wenling Wang
    Suyu Zhu
    Jialin Yang
    Yexiong Li
    Dongbing Zhao
    Jing Jin
    BMC Gastroenterology, 22
  • [15] Efficacy and safety of cadonilimab combined with FLOT regimen as a neoadjuvant therapy for locally advanced gastric/gastroesophageal junction adenocarcinoma: A prospective, multicenter, open-label, single-arm phase II study
    Long, B.
    Zhou, H.
    Wei, D.
    Yang, T.
    Chai, N.
    Yu, Z.
    Yang, H.
    Guan, X.
    Zhang, W.
    Chen, S.
    Zhou, L.
    Jiang, X.
    Shi, W.
    Huang, Z.
    Zhu, J.
    Luo, C.
    Mao, J.
    Dong, C.
    Jiang, Z.
    Zhao, X.
    Zhao, D.
    Jiao, Z.
    ANNALS OF ONCOLOGY, 2023, 34 : S70 - S71
  • [16] Split-course hypofraction radiotherapy combined with chemotherapy and tislelizumab as preoperative treatment for locally advanced rectal cancer: Interim analysis of a prospective, single-arm phase II trial
    Zheng, R.
    Chen, S.
    Hong, Y.
    Huang, X.
    Shi, G.
    Chen, Z.
    Wang, L.
    Yang, Y.
    Jiang, W.
    Chi, P.
    Xu, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S1435 - S1435
  • [17] Combining chemotherapy and tislelizumab with preoperative split-course hypofraction radiotherapy for locally advanced rectal cancer: study protocol of a prospective, single-arm, phase II trial
    Zheng, Rong
    Wang, Bi-Si
    Li, Zhihua
    Chi, Pan
    Xu, Benhua
    BMJ OPEN, 2023, 13 (03):
  • [18] R-IMMUNE: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radiochemotherapy in a preoperative setting for patients with locally advanced rectal cancer (LARC)
    Carrasco, J.
    Beniuga, G.
    Jouret-Mourin, A.
    Baldin, P.
    Sinapi, I.
    Schroeder, D.
    De Cuyper, A.
    Sclafani, F.
    Hendlisz, A.
    van Laethem, J-L.
    Boulanger, A-S.
    Van Ooteghem, G.
    Dermine, A.
    Delmarcelle, S.
    Huyghe, N.
    Bar, I.
    van den Eynde, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S432 - S432
  • [19] Preliminary efficacy and safety of total neoadjuvant therapy combined with PD-L1 blockade in pMMR/MSS locally advanced rectal cancer (ESTIMATE): A prospective, single-arm, phase II trial
    Zhang, Xuan, Sr.
    Feng, Qing, Jr.
    Cai, Xinyi, Sr.
    Yu, Kun, Sr.
    Shen, Tao, Sr.
    Pan, Dingguo, Sr.
    Tan, Jing, Sr.
    Ju, Yunhe, Sr.
    Zhang, Lijuan, Sr.
    Xie, Lin, Sr.
    Dong, Jianhua, Sr.
    Xia, Cuifeng, Sr.
    Xiong, Wei, Sr.
    Yang, Quan, Jr.
    Wu, Tao, Jr.
    Li, Yun-Feng, Sr.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [20] Panitumumab in Combination With Preoperative Radiation Therapy in Patients With Locally Advanced RAS Wild-type Rectal Cancer: Results of the Multicenter Explorative Single-Arm Phase 2 Study NEORIT
    Merx, Kirsten
    Martens, Uwe M.
    Kripp, Melanie
    Hoehler, Thomas
    Geissler, Michael
    Gaiser, Timo
    Mai, Sabine
    Kienle, Peter
    Belle, Sebastian
    Ploeger, Christoph
    Hieber, Udo
    Wenz, Frederik
    Post, Stefan
    Hofheinz, Ralf D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (04): : 867 - 875
1234